We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Draft Version of the Neanderthal Genome Completed

By LabMedica International staff writers
Posted on 11 Mar 2009
Print article
Scientists have just completed a first draft version of the Neanderthal genome.

The Max Planck Institute for Evolutionary Anthropology (Leipzig, Germany) and the 454 Life Sciences Corp. (Branford, CT, USA) presented their findings February 12, 2009, during the 2009 annual meeting of the American Association for the Advancement of Science (AAAS), in Chicago, IL, USA, and at a simultaneous European press briefing.

The project is directed by Prof. Svante Pääbo, director of the Institute's department of evolutionary genetics anthropology. The professor and his colleagues have sequenced more than one billion DNA fragments extracted from three Croatian Neanderthal fossils, using innovative techniques developed for this project. The Neanderthal genome sequence will clarify the evolutionary relationship between humans and Neanderthals as well as help identify those genetic changes that enabled modern humans to leave Africa and rapidly spread around the world, starting approximately 100,000 years ago.

Neanderthals (sp. Homo neanderthalensis) were the closest relatives of currently living humans. They lived in Europe and parts of Asia until they became extinct approximately 30,000 years ago. For more than 100 years, paleontologists and anthropologists have been trying to uncover their evolutionary relationship to modern humans. Prof. Pääbo, a pioneer in the field of ancient DNA research, made the first contribution to the understanding of our genetic relationship to Neanderthals when he sequenced Neanderthal mitochondrial DNA in 1997. Together with the company 454 Life Sciences, Prof. Pääbo has now reported on a new milestone in Neanderthal research. The two groups have sequenced a total of more than 3 billion bases of Neanderthal DNA, generating a first draft sequence of the entire Neanderthal genome. Altogether, these fragments comprise more than 60% of the entire Neanderthal genome. These DNA sequences can now be compared to the earlier sequenced human and chimpanzee genomes in order to arrive at some initial insights into how the genome of this extinct form differed from that of modern humans.

In 2006, Prof. Pääbo's group published papers together with 454 Life Sciences that showed that it was possible to use the 454 technology to determine large amounts of nuclear DNA sequences from late Pleistocene animals such as mammoths as well as the Neanderthal. Building on these findings, Prof. Pääbo and Dr. Michael Egholm, vice president of Research and Technology of 454 Life Sciences, initiated an ambitious project to sequence the Neanderthal genome. Together, the groups have overcome a number of technical obstacles in order to arrive at this first view of the entire genome of an extinct form of human.

One key element developed by Dr. Pääbo's group was the production of sequencing libraries under "clean-room” conditions to avoid contamination of experiments by human DNA. They also designed DNA sequence tags that carry unique identifiers and are attached to the ancient DNA molecules in the clean room. This makes it possible to avoid contamination from other sources of DNA during the sequencing procedure, which was a hurdle in the initial proof-of-principle experiments in 2006. They also used minute amounts of radioactively labeled DNA to identify and modify those steps in the sequencing procedure where losses occur. Together with other developments implemented during the project, these innovations drastically reduced the need for precious fossil material so that less than half a gram of bone was used to produce the draft sequence of three billion base pairs.

In order to effectively compare the Neanderthal DNA sequences to those of humans and chimpanzees, the Leipzig research group has performed detailed studies of where chemical damage tends to occur in the ancient DNA and how it causes errors in the DNA sequences. The researchers found that such errors occur most frequently towards the ends of molecules and that most of them are due to a specific modification of one of the bases in the DNA that occurs over time in fossil remains. They then applied this knowledge to identify which of the DNA fragments from the fossils come from the Neanderthal genome and which from microorganisms that have colonized the bones during the thousands of years they lay buried in the caves. They have also developed novel and more sensitive computer algorithms to put the Neanderthal DNA fragments in order and compare them to the human genome.

In total, the group has determined over 100 million DNA sequence fragments from fossils by the 454 technology and over a billion DNA sequences with the Solexa technology, another sequencing technology that is particularly efficient in reading many short sequences. The majority of the sequence comes from Neanderthal bones from Vindija Cave in Croatia, which the group studies as a part of a long-term collaboration between the Croatian Academy of Sciences and Arts (Zagreb) and the Berlin-Brandenburg (Germany) Academy. To assess if the findings from this Neanderthal are typical of those of other Neanderthals, the researchers have also sequenced several million base pairs from Neanderthals from other sites.

Prof. Javier Fortea and colleagues from Oviedo, Spain, have excavated 43,000-year-old Neanderthal bones under sterile conditions at El Sidron, Spain, that have yielded DNA sequences, while Dr. Lubov Golovanova and Dr. Vladimir Doronichev from St. Petersburg, Russia, have contributed a 60-70,000-year-old bone from Mezmaiskaya Cave in the Caucasus. Moreover, Dr. Ralf Schmitz from the LVR-Landesmuseum in Bonn, Germany has allowed a sample to be removed from the 40,000-year-old Neanderthal type specimen, which was found in 1856 in the Neander Valley, the origin of the name, Neanderthal. This will allow important findings from the Croatian Neanderthal to be verified in several Neanderthals including the specimen that defines the Neanderthals as a distinct group.

In order to aid in the analysis of the Neanderthal genome, Prof. Pääbo has organized a consortium of researchers worldwide that plans to publish their results later in 2009. They will look at many genes of special interest in recent human evolution, such as FOXP2, which is involved in speech and language in modern humans, as well as genes such as the Tau locus and the microcephalin-1, implicated in brain aging and development, respectively. Variants of the latter genes found among present-day humans have been suggested to come from Neanderthals. The preliminary results suggest that Neanderthals have contributed, at most, a very small fraction of the variation found in contemporary human populations.

Related Links:

Max Planck Institute for Evolutionary Anthropology
454 Life Sciences


Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test
Automated Blood Typing System
IH-500 NEXT
New
Quantitative Immunoassay Analyzer
AS050
New
Adenovirus Detection Kit
REALQUALITY RQ-ADENO

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: Small molecule modulation of protein corona significantly enhances deep plasma proteome profiling (Photo courtesy of Mahmoudi Group)

Smarter Blood Tests Deliver Faster Diagnoses and Improved Outcomes

It has long been established that the earlier a disease is detected, the better the chances for a positive patient outcome. A novel method now offers an in-depth analysis of proteins in plasma, uncovering... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: Photoacoustic images of a splayed vessel structure underlying very light and dark skin tones (Photo courtesy of asquinha, Gubbi, and Bell, doi 10.1117/1.BIOS.2.1.012502)

New Imaging Technique Reduces Skin Tone Bias in Breast Cancer Detection

Breast cancer remains a significant global health issue, and early detection is key to successful treatment. Traditional imaging techniques like mammography often face challenges, particularly for women... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.